A detailed history of Jump Financial, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 21,494 shares of TNGX stock, worth $179,259. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,494
Holding current value
$179,259
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$7.51 - $12.88 $161,419 - $276,842
21,494 New
21,494 $170,000
Q1 2023

May 03, 2023

SELL
$3.76 - $8.06 $20,804 - $44,595
-5,533 Reduced 30.65%
12,518 $49,000
Q4 2022

Feb 13, 2023

BUY
$3.41 - $8.29 $15,382 - $37,396
4,511 Added 33.32%
18,051 $130,000
Q3 2022

Nov 07, 2022

BUY
$3.25 - $5.46 $44,005 - $73,928
13,540 New
13,540 $49,000

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $734M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.